2023 [67] found that promoter hypomethylation of the SOCS1 gene was significantly associated with severe COVID‐19 outcomes, while a SOCS1 polymorphism (rs33989964) was linked to increased disease severity. This evidence concerns the gene SOCS1 and COVID-19.